Ezetimibe is a selective cholesterol absorption inhibitor that functions by blocking the Niemann-Pick C1-Like 1 (NPC1L1) transporter in the small intestine, making it an essential medication for treating… Read more
![Chemical structure of ((4R)-3-[(5S)-5-(4-Fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F404874-94-8-4R-3-5S-5-4-Fluorophenyl-5-hydroxypentanoyl-4-phenyl-13-oxazolidin-2-one.png&w=3840&q=75)



![Chemical structure of (3R,4S)-1-(4-Fluorophenyl)-2-oxo-4-[4-(phenylmethoxy)phenyl]-3-azetidinepropanoic acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F204589-82-2-3R4S-1-4-Fluorophenyl-2-oxo-4-4-phenylmethoxyphenyl-3-azetidinepropanoic-acid.png&w=3840&q=75)

![Chemical structure of (3R,4S)-1-(4-Fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-[(trimethylsilyl)oxy]propyl]-4-[4-(phenylmethoxy)phenyl]-2-azetidinone](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1197343-09-1-3R4S-1-4-Fluorophenyl-3-3S-3-4-fluorophenyl-3-trimethylsilyloxypropyl-4-4-phenylmethoxyphenyl-2-azetidinone.png&w=3840&q=75)








methyl]-5-hydroxy-1-oxopentyl]-4-phenyl-2-oxazolidinone](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1185883-40-2-4S-3-2R5S-5-4-Fluorophenyl-2-S-4-fluorophenylamino4-hydroxyphenylmethyl-5-hydroxy-1-oxopentyl-4-phenyl-2-oxazolidinone.png&w=3840&q=75)
![Chemical structure of (4S3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl)amino][4-[(trimethylsilyl)oxy]phenyl]methyl]-1-oxo-5-[(trimethylsilyl)oxy]pentyl]-4-phenyl-2-oxazolidinone](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F272778-12-8-4S3-2R5S-5-4-Fluorophenyl-2-S-4-fluorophenylamino4-trimethylsilyloxyphenylmethyl-1-oxo-5-trimethylsilyloxypentyl-4-phenyl-2-oxazolidinone.png&w=3840&q=75)

















![Chemical structure of 1-Phenyl 3(R)-[3(S)-(4-Fluorophenyl)-3-hydroxypropyl]-4(S)-(4-hydroxyphenyl)azetidin-2-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1-Phenyl-3R-3S-4-Fluorophenyl-3-hydroxypropyl-4S-4-hydroxyphenylazetidin-2-one.png&w=3840&q=75)


![Chemical structure of 3-[5-(1,5-Dioxo-5-(p-fluophenylpentyl]-4(S)-phenyl-2-oxazolidinone](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F189028-93-1-3-5-15-Dioxo-5-p-fluophenylpentyl-4S-phenyl-2-oxazolidinone.png&w=3840&q=75)
![Chemical structure of 3-[5-(4-Fluoro-phenyl)-5-(S)-hydroxy-pentanoyl]-4-(S)-phenyl-oxazolidin-2-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F189028-95-3-3-5-4-Fluoro-phenyl-5-S-hydroxy-pentanoyl-4-S-phenyl-oxazolidin-2-one.png&w=3840&q=75)







Ezetimibe is a selective cholesterol absorption inhibitor that functions by blocking the Niemann-Pick C1-Like 1 (NPC1L1) transporter in the small intestine, making it an essential medication for treating primary hypercholesterolemia and managing cardiovascular disease risk. To support the rigorous demands of pharmaceutical quality control and regulatory compliance, this category provides a comprehensive range of Ezetimibe reference standards, including pharmacopeial and non-pharmacopeial impurities, degradation products, and structural analogs. These compounds are vital for conducting impurity profiling, forced degradation studies, and the development and validation of robust analytical methods. Furthermore, the availability of stable isotope labelled compounds allows laboratories to perform accurate quantification in complex bioanalytical assays. By utilizing these high-quality reference materials, pharmaceutical researchers can ensure consistent product performance, satisfy international pharmacopeial guidance, and maintain high standards throughout the lifecycle of Ezetimibe-based drug development and manufacturing.